The World Health Organization has approved the emergency-use listing of Johnson & Johnson’s COVID-19 vaccine, the U.N. agency said on Friday, broadening access to the shots.
It is the third COVID-19 vaccine after those of Pfizer/BioNTech and AstraZeneca to receive backing from the WHO.
The listing covers use in all countries and for the vaccine platform COVAX’s roll-out.
Biden administration purchases 100 million additional Johnson and Johnson vaccines
The decision comes on the back of European Medicines Agency (EMA) authorization announced on Thursday.
“Every new, safe and effective tool against COVID-19 is another step closer to controlling the pandemic,” WHO Director-General Tedros Adhanom Ghebreyesus said in a statement.
“But the hope offered by these tools will not materialize unless they are made available to all people in all countries.”
[ Sign up for our Health IQ newsletter for the latest coronavirus updates ]
(Reporting by Stephanie Nebehay and Emma Farge; Editing by Michael Shields and Hugh Lawson)
© 2021 Reuters
